World's Best Scientists 2026 revealed!
S. Matthijs Boekholdt

S. Matthijs Boekholdt

D-Index & Metrics

Medicine

D-Index
90
Citations
34954
World Ranking
12087
National Ranking
466

Overview

S. Matthijs Boekholdt is affiliated with the University of Amsterdam in the Netherlands and has contributed extensively to the field of medicine, with a particular focus on cardiology and cardiovascular medicine. Their research encompasses multiple subfields including radiology, nuclear medicine and imaging, epidemiology, surgery, and pulmonary and respiratory medicine.

The scientist's publication record features numerous studies in prominent journals, reflecting a focus on cardiovascular health, diagnostic imaging, and disease mechanisms. Notable recent papers include:

  • "Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect" (2021, Nature Genetics)
  • "Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention" (2020, European Heart Journal)
  • "Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis" (2020, JACC Basic to Translational Science)
  • "Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification" (2022, European Heart Journal)
  • "Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality" (2020, JAMA Cardiology)

Boekholdt's co-authors frequently include R. Nils Planken, H T Jørstad, Adriënne van Randen, Nicholas J. Wareham, and Maarten Groenink, indicating a strong collaborative network in cardiovascular research.

The individual has a strong presence in several key journals, with frequent publications in the European Heart Journal, European Journal of Preventive Cardiology, Heart, Atherosclerosis, and Stroke. This points to a focus on both clinical and preventive cardiology aspects.

The main areas of study span a broad range of cardiovascular medicine topics. These cover cardiac imaging and diagnostics, cardiovascular effects of exercise, cardiac valve diseases and treatments, infective endocarditis diagnosis and management, lipoproteins and cardiovascular health, cardiovascular function and risk factors, and advanced MRI techniques and applications.

Boekholdt's academic output primarily centers on:

  • Cardiac Imaging and Diagnostics
  • Cardiovascular Effects of Exercise
  • Cardiac Valve Diseases and Treatments
  • Infective Endocarditis Diagnosis and Management
  • Lipoproteins and Cardiovascular Health
  • Cardiovascular Function and Risk Factors
  • Advanced MRI Techniques and Applications

Overall, the research profile of S. Matthijs Boekholdt reflects comprehensive engagement with the interconnected areas of cardiovascular disease research, diagnostic innovation, and preventive strategies.

Best Publications

  • Biological, clinical and population relevance of 95 loci for blood lipids

    Tanya M. Teslovich;Kiran Musunuru;Albert V. Smith;Andrew C. Edmondson

  • Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease

    Heribert Schunkert;Inke R. König;Sekar Kathiresan;Muredach P. Reilly

  • Triglycerides and the Risk of Coronary Heart Disease 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies

    Nadeem Sarwar;John Danesh;Gudny Eiriksdottir;Gunnar Sigurdsson

  • Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins: A Meta-analysis

    S. Matthijs Boekholdt;Benoit J. Arsenault;Samia Mora;Terje R. Pedersen

  • Triglyceride-mediated pathways and coronary disease : collaborative analysis of 101 studies

    N Sarwar;M S Sandhu

  • Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: A meta-analysis of statin trials

    S. Matthijs Boekholdt;G. Kees Hovingh;Samia Mora;Benoit J. Arsenault

  • Body Fat Distribution and Risk of Coronary Heart Disease in Men and Women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk Cohort A Population-Based Prospective Study

    Dexter Canoy;S. Matthijs Boekholdt;Nicholas Wareham;Robert Luben

  • Lipid-related markers and cardiovascular disease prediction.

    E Di Angelantonio;P Gao;L Pennells

  • Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment

    John J.P. Kastelein;Wim A. van der Steeg;Ingar Holme;Michael Gaffney

  • High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.

    Wim A. van der Steeg;Ingar Holme;S. Matthijs Boekholdt;Mogens Lytken Larsen

  • Serum Myeloperoxidase Levels Are Associated With the Future Risk of Coronary Artery Disease in Apparently Healthy Individuals: The EPIC-Norfolk Prospective Population Study

    Marijn C. Meuwese;Erik S G Stroes;Stanley L. Hazen;Joram N. van Miert

  • Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study.

    Danish Saleheen;Robert Scott;Sundas Javad;Wei Zhao

  • Genetic variants influencing circulating lipid levels and risk of coronary artery disease.

    Dawn M. Waterworth;Sally L. Ricketts;Kijoung Song;Li Chen

  • Cholesteryl Ester Transfer Protein TaqIB Variant, High-Density Lipoprotein Cholesterol Levels, Cardiovascular Risk, and Efficacy of Pravastatin Treatment Individual Patient Meta-Analysis of 13 677 Subjects

    S.M. Boekholdt;F.M. Sacks;J.W. Jukema;J. Shepherd

  • Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women.

    Benoit J. Arsenault;Jamal S. Rana;Erik S.G. Stroes;Jean-Pierre Després

  • The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults : the good the bad and the uncertain : a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011

    Kausik K. Ray;John J.P. Kastelein;S. Matthijs Boekholdt;Stephen J. Nicholls

  • Ability of Recombinant Factor VIIa to Reverse the Anticoagulant Effect of the Pentasaccharide Fondaparinux in Healthy Volunteers

    Nick R. Bijsterveld;Arno H. Moons;S. Matthijs Boekholdt;Benien E. van Aken

  • Value of Low-Density Lipoprotein Particle Number and Size as Predictors of Coronary Artery Disease in Apparently Healthy Men and Women: The EPIC-Norfolk Prospective Population Study

    Karim El Harchaoui;Wim A. van der Steeg;Erik S.G. Stroes;Jan Albert Kuivenhoven

  • HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial.

    Paul M. Ridker;Jacques Genest;S. Matthijs Boekholdt;Peter Libby

  • Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study.

    S. Matthijs Boekholdt;Jan-Albert Kuivenhoven;Nicholas J. Wareham;Ron J.G. Peters

Frequent Co-Authors

Kay-Tee Khaw
Kay-Tee Khaw University of Cambridge
Nicholas J. Wareham
Nicholas J. Wareham University of Cambridge
John J.P. Kastelein
John J.P. Kastelein University of Amsterdam
Erik S.G. Stroes
Erik S.G. Stroes University of Amsterdam
Robert Luben
Robert Luben University College London
G. Kees Hovingh
G. Kees Hovingh University of Amsterdam
Manjinder S. Sandhu
Manjinder S. Sandhu Imperial College London
Philip J. Barter
Philip J. Barter University of New South Wales
J. Wouter Jukema
J. Wouter Jukema Leiden University Medical Center
Jean-Pierre Després
Jean-Pierre Després Université Laval

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The path to a medical career in the USA is diverse, with many students considering alternative or supplementary fields such as nursing. Online degrees have rapidly become a popular and flexible option for those looking to enter or advance in healthcare professions.

For those aiming to fast-track their nursing qualification, exploring the cheapest online accelerated bsn programs can help minimize costs and time without sacrificing educational quality. Many registered nurses interested in furthering their skills may investigate the average cost of rn to bsn programs to make informed decisions about continuing their education affordably.

Non-nursing majors seeking swift entry into advanced practice roles could consider the direct entry msn programs for non-nursing majors, which offer streamlined routes into the nursing field. Those already holding advanced nursing qualifications may look to further their expertise, and programs like an online phd nursing can open doors to leadership, research, and academic positions.

Whether you are starting your journey or seeking to advance your healthcare career, these online degree pathways provide flexible and affordable options to meet your goals.

Best Scientists Citing S. Matthijs Boekholdt

Trending Scientists